Raymond James Downgrades Acadia Pharmaceuticals (ACAD) to Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/25/2024
Go back to Raymond James Downgrades Acadia Pharmaceuticals (ACAD) to Outperform
March 8, 2021 4:30 PM EST
Exhibit 99.1
Acadia Pharmaceuticals Provides Regulatory Update on
Supplemental New Drug Application for Pimavanserin for the Treatment of
Hallucinations and Delusions Associated with Dementia-Related Psychosis... More